What regulatory issues must B2B companies address when including content on webmd.com?© BrainMass Inc. brainmass.com June 3, 2020, 9:45 pm ad1c9bdddf
What regulatory issues must B2B companies address when including content on webmd.com?
The first regulatory issue that B2B companies must address is the publication of trade secrets. The provisions of The Uniform Trade Secrets Act must be adhered to. If any medical pattern, formulae, method of cure or technique that has independent economic value from not being know to and ascertainable by proper means, and is the subject of effort to maintain its secrecy are displayed on webmd.com, then the website can be accused of misappropriation. The Uniform Trade Secrets Act will impose civil ...
This explanation provides you a comprehensive argument relating to B2B Regulatory issues.